Horizon Therapeutics Public Limited Company (HZNP)
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Currently, Horizon Therapeutics Public stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean HZNP will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
"To sell or not to sell", if you are holding Horizon Therapeutics Public shares?. Like when we have to buy shares, determining when is appropiate to sell is not a haphazard decision, and we must adhere our own trading style. When selling, as well as buying, detailed strategies are very simple to use and are only applicable for selling stocks in your porfolio, not for shorting HZNP stock
As a rule of thumb, you must never hold a trading operation that leads to higher than expected losses at the time of the buy. The timing to sell your stock should always be dictated by the stop-loss (automatic or manual)
Currently, Horizon Therapeutics Public stock doesn't match any of our preferred sell setups, so if you hold Horizon Therapeutics Public shares and your operation is in profit probably is not time to sell now
Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal
In the last 30 days, just one analyst rating was published for Horizon Therapeutics Public
|Sep 9th, 2020|
|JPMorgan Chase & Co.||Buy|
Since last March, Horizon Therapeutics Public has been printing an uptrend that by now marked an amazing 228.64%. The price action shows higher peaks and higher lows, and along the way provided some entry points for those who wanted to trade in. Latest pullback was on September 4, when price bounced at $66.50. Now, the price trades in a consolidation between its last top ($82.60) and its last bottom ($66.50)
Horizon Therapeutics Public did it again, and hit new all-time highs (ATH) on Wednesday at $82.60
Moving averages are indicators for traders to measure direction. A moving average is the average price of a stock over a set period of time. Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days
Traders use supports and resistances to identify price points in the stock price action that tend to work as obstacles, preventing the price of a stock to move up or down. Supports are levels where the price tends to find support as it falls. Price is more likely to "bounce off" this level rather than break through it. Nevertheless, if the price breaks down this level, it will probably continue descending until meeting another support level. On the other hand, resistances are where the price may find resistance as it rises. Again, the price is more likely to "bounce off" at this level, and if it finally crosses this level, it will rally easily until it approaches the next resistance
The current resistance levels are:
The current support levels are:
The so-called Bollinger bands are a widespread technique designed by John Bollinger. Fundamentally, the Bollinger Bands are lines that move around a moving average, ranging the distance from the bottom to the top depending on market volatility. They are usually plotted by an offset of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20
Since the price surpassed the upper band on September 18, the price has been corrected downwards by 3.61%
The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. Its objective is to chart the current and historical strength or weakness of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI fluctuates in a range from 0 to 100. J. Welles Wilder introduced the relative strength indicator in 1978 and since then it has been widely used by stock traders
The RSI dropped below the overbought level of 70 in mid-August after just crossing to the overbough zone for just one day (weak signal). The RSI value on Friday was 57.42. Since RSI lost the overbought zone, Horizon Therapeutics Public shares exploded a 3.18%
In early August, HZNP hosted the financial call and presented the second-quarter report. HZNP reported 2nd-quarter earnings of $0.40 per share on revenue of $462.8 million. The analysts estimate was $0.36 per share on revenue of $301.3 million.
This compares to earnings of $0.49 per share a year ago, so posted EPS is a decrease of -18.37%. Looking at revenue, figures exploded a 44.33% compared to $320.6M same quarter a year ago.
HZNP is posting Q3 earnings report on early next November. Estimated Earnings per Share for this quarter is $0.94. If you hold or you are considering buying HZNP shares, be aware that earnings reporting day usually has a very high volatility, and price can gap up or down with unsually low liquidity and not honouring your buy/stop-loss orders. Check company's website to confirm time and details on the earnings call and the earnings report.